阿波利波蛋白E多态性与殖民地刺激因子1受体相关疾病的发病年龄和神经病理有关
Tomasz Chmiela1,2, Shanu Roemer3, Audrey J Strongosky1
1Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA.
概括
ApoE4等位基因不会改变殖民地刺激因子1受体相关疾病 (CSF1R-RD) 的频率,但与更早的症状发作和更严重的白质损伤有关. 这表明ApoE4可能会改变CSF1R-RD进展.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 病理学 病理学 病理学
背景情况:
- 殖民地刺激因子1受体相关疾病 (CSF1R-RD) 是一种罕见的,具有多种症状的侵袭性神经退行性疾病.
- 已知Apolipoprotein E (ApoE) 基因变异会影响大脑健康和神经退行,可能会影响CSF1R-RD.
研究的目的:
- 为了确定与CSF1R-RD.个体的ApoE等位基因的频率.
- 调查ApoE基因型是否与CSF1R-RD.的临床和神经病理特征有关.
主要方法:
- 在55名CSF1R-RD患者中进行了ApoE基因型鉴定.
- 来自25名已故患者的临床数据和来自14名患者的神经病理数据基于ApoE基因型进行了分析,重点关注白质病理和微质负担.
主要成果:
- 在CSF1R-RD患者中的ApoE等位基因频率与一般人群相似.
- 与非携带者相比,ApoE4携带者出现症状和死亡的时间明显较早.
- 神经病理学检查显示,ApoE4载体中白质损伤增加和微质保存减少.
结论:
- 在CSF1R-RD中,ApoE等位基因分布没有改变.
- ApoE4等位基因可能充当基因修饰剂,影响CSF1R-RD的临床过程和白质病理学.
- 建议在CSF1R-RD研究和治疗计划中考虑ApoE多态性.
更多相关视频
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
15.6K
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
8.2K
相关概念视频
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
03:03Amyloid Fibrils
11.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.6K